Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald.

Slides:



Advertisements
Similar presentations
Coagulation Or Clotting of Blood
Advertisements

HEMOSTASIS. Due to damaged blood vessels Events that stop bleeding.
The Massive Transfusion Protocol An Aide Memoire 1.
General Principles of Hemostasis Kristine Krafts, M.D.
Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1 by Ilka Ott, Martin.
Factor XIII in plasma, but not in platelets, mediates red blood cell retention in clots and venous thrombus size in mice by Sravya Kattula, James R. Byrnes,
Arterioscler Thromb Vasc Biol
Activation of factor XI by products of prothrombin activation
Thrombin and fibrinogen γ′ impact clot structure by marked effects on intrafibrillar structure and protofibril packing by Marco M. Domingues, Fraser L.
Dasatinib suppresses in vitro natural killer cell cytotoxicity
Heparinless cardiopulmonary bypass with active-site blocked factor IXa: A preliminary study on the dog  Talia B. Spanier, MDa, Mehmet C. Oz, MDa, Oktavijan.
Tissue-Specific Expression of Functional Platelet Factor XI Is Independent of Plasma Factor XI Expression by Chang-jun Hu, Frank A. Baglia, David C.B.
Polyphosphates rock! A role in thrombosis?
by Mark S. Hertzberg, Sandra L. Facey, and Philip J. Hogg
Kinetics and mechanics of clot contraction are governed by the molecular and cellular composition of the blood by Valerie Tutwiler, Rustem I. Litvinov,
Factor XIIIa-dependent retention of red blood cells in clots is mediated by fibrin α-chain crosslinking by James R. Byrnes, Cédric Duval, Yiming Wang,
Recombinant factor VIIa restores aggregation of αIIbβ3-deficient platelets via tissue factor–independent fibrin generation by Ton Lisman, Jelle Adelmeijer,
Effects of inflammatory cytokines on the release and cleavage of the endothelial cell–derived ultralarge von Willebrand factor multimers under flow by.
Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy by William Breuer, Marieke J. J.
Distinct dose-dependent effects of plasmin and TPA on coagulation and hemorrhage by Daphne Stewart, Mansze Kong, Valery Novokhatny, Gary Jesmok, and Victor.
Agonist-induced aggregation of Chinese hamster ovary cells coexpressing the human receptors for fibrinogen (integrin αIIbβ3) and the platelet-activating.
Generation of enhanced stability factor VIII variants by replacement of charged residues at the A2 domain interface by Hironao Wakabayashi, Fatbardha Varfaj,
Lineages of human T-cell clones, including T helper 17/T helper 1 cells, isolated at different stages of anti–factor VIII immune responses by Ruth A. Ettinger,
Alterations in platelet secretion differentially affect thrombosis and hemostasis by Smita Joshi, Meenakshi Banerjee, Jinchao Zhang, Akhil Kesaraju, Irina.
by Laurent O. Mosnier, Paula Buijtenhuijs, Pauline F. Marx, Joost C. M
Blood Clotting Assignment
A role for the thiol isomerase protein ERP5 in platelet function
Thrombin generation: biochemical possibilities and clinical reality
A.R. Wufsus, N.E. Macera, K.B. Neeves  Biophysical Journal 
The γ-carboxyglutamic acid domain of anticoagulant protein S is involved in activated protein C cofactor activity, independently of phospholipid binding.
The interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies by.
by Harish Shankaran, Paschalis Alexandridis, and Sriram Neelamegham
Serum amyloid A is an innate immune opsonin for Gram-negative bacteria
Volume 98, Issue 9, Pages (May 2010)
Brain-derived microparticles induce systemic coagulation in a murine model of traumatic brain injury by Ye Tian, Breia Salsbery, Min Wang, Hengjie Yuan,
Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia by Lubica Rauova, Mortimer Poncz, Steven E.
Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency by Joseph S. Palumbo, Kathryn E. Talmage, Hong Liu,
by Cornelis van 't Veer, Neal J. Golden, and Kenneth G. Mann
Apoptotic Vascular Endothelial Cells Become Procoagulant
Molecular Mechanism of a Mild Phenotype in Coagulation Factor XIII (FXIII) Deficiency: A Splicing Mutation Permitting Partial Correct Splicing of FXIII.
Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent.
Conservative mutations in the C2 domains of factor VIII and factor V alter phospholipid binding and cofactor activity by Gary E. Gilbert, Valerie A. Novakovic,
Mechanism of factor VIIa–dependent coagulation in hemophilia blood
A new red cell shape helps the clot
Volume 102, Issue 10, Pages (May 2012)
A Novel Approach to Arterial Thrombolysis
Causal relationship between hyperfibrinogenemia, thrombosis, and resistance to thrombolysis in mice by Kellie R. Machlus, Jessica C. Cardenas, Frank C.
General Principles of Hemostasis Kristine Krafts, M.D.
Very low-density lipoprotein stimulates the expression of monocyte chemoattractant protein-1 in mesangial cells  Edward G. Lynn, Yaw L. Siow, Dr Karmin.
Volume 89, Issue 5, Pages (May 1997)
Cell-derived vesicles exposing coagulant tissue factor in saliva
Comparison of reversal activity and mechanism of action of UHRA, andexanet, and PER977 on heparin and oral FXa inhibitors by Manu T. Kalathottukaren, A.
Abnormal plasma clot formation and fibrinolysis reveal bleeding tendency in patients with partial factor XI deficiency by Gillian N. Gidley, Lori A. Holle,
Preventing Blood Loss a,b,c,d.
Platelet HMGB1 is required for efficient bacterial clearance in intra-abdominal bacterial sepsis in mice by Hui Zhou, Meihong Deng, Yingjie Liu, Chenxuan.
Volume 98, Issue 9, Pages (May 2010)
by Ludovic Durrieu, Alamelu Bharadwaj, and David M. Waisman
Human antibodies with specificity for the C2 domain of factor VIII are derived from VH1 germline genes by Edward N. van den Brink, Ellen A. M. Turenhout,
Earlham High School Anatomy Class Cardiovascular System.
by Guojie Wu, Blake A. Mazzitelli, Adam J. Quek, Matthew J
Platelet cytoplasmic calcium concentration in PI3Kγ-null platelets.
Platelet cytoplasmic calcium concentration in PLCβ2/β3-null platelets.
Complement activation by synthetic vascular prostheses
Sickle cells and sickle trait in thrombosis
by Sarah M. Nordstrom, Brian A. Holliday, Brandon C. Sos, James W
Trousseau's syndrome: multiple definitions and multiple mechanisms
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: mode of its action by Shiva Keshava, Jagan Sundaram,
Reduced prothrombinase inhibition by tissue factor pathway inhibitor contributes to the factor V Leiden hypercoagulable state by Jeremy P. Wood, Lisa M.
Patient Tregs express normal levels of suppression.
Activated protein C light chain provides an extended binding surface for its anticoagulant cofactor, protein S by José A. Fernández, Xiao Xu, Ranjeet K.
Presentation transcript:

Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk by Alisa S. Wolberg, Dougald M. Monroe, Harold R. Roberts, and Maureane Hoffman Blood Volume 101(8):3008-3013 April 15, 2003 ©2003 by American Society of Hematology

Thrombin generation is dependent on the initial prothrombin concentration.Tissue factor–bearing cells were incubated with unactivated platelets, catalytic amounts of factor VIIa, calcium (3 mM), and plasma concentrations of factors IX, X, V, VIII, ATIII, an... Thrombin generation is dependent on the initial prothrombin concentration.Tissue factor–bearing cells were incubated with unactivated platelets, catalytic amounts of factor VIIa, calcium (3 mM), and plasma concentrations of factors IX, X, V, VIII, ATIII, and TFPI with increasing concentrations of prothrombin. At the times shown, samples were removed and assayed for the amount of thrombin as described in “Materials and methods.” Symbols: 0% (○), 1% (■), 10% (⋄), 50% (▵), 100% (●), 150% (▪), 200% (♦), and 300% (▴) of plasma levels. The absolute amounts of thrombin generated in each assay differed, depending on the procoagulant potential of the donor's platelets.33 Therefore, the data shown are representative of experiments with 8 different donors. (A) Thrombin generation profile from 0 to 60 minutes after the reaction start; (B) thrombin generation profile showing only the first 15 minutes of a reaction course. Panels A and B are from separate experiments using different donor platelets. Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology

Fibrin clot formation is dependent on the initial prothrombin concentration.The model plasma system was incubated with 2 mg/mL fibrinogen and the level of prothrombin (0% ○, 1% ■, 10% ⋄, 50% ▵, 100% ●, 150% ▪, 200% ♦, and 300% ▴ of plasma levels) was varied. Fibrin clot formation is dependent on the initial prothrombin concentration.The model plasma system was incubated with 2 mg/mL fibrinogen and the level of prothrombin (0% ○, 1% ■, 10% ⋄, 50% ▵, 100% ●, 150% ▪, 200% ♦, and 300% ▴ of plasma levels) was varied. Clot formation was monitored by an increase in optical density. Data shown are representative of 10 experiments. Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology

The mass-to-length ratio of fibrin fibers is dependent on the initial concentration of prothrombin.Mass-to-length ratios were calculated by scanning the fibrin clots from 400 to 800 nm, as described in “Materials and methods.” Values were then normalized, s... The mass-to-length ratio of fibrin fibers is dependent on the initial concentration of prothrombin.Mass-to-length ratios were calculated by scanning the fibrin clots from 400 to 800 nm, as described in “Materials and methods.” Values were then normalized, such that 100% of plasma levels of prothrombin were set equal to 1. Note that the y-axis does not begin at 0. Data shown are representative of measurements on 9 experiments. Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology

Clots formed from plasma samples with elevated prothrombin levels contain fibrin fibers with smaller mass-to-length ratios.Platelet-rich plasma samples were collected from healthy donors and spiked with purified prothrombin to achieve prothrombin levels mor... Clots formed from plasma samples with elevated prothrombin levels contain fibrin fibers with smaller mass-to-length ratios.Platelet-rich plasma samples were collected from healthy donors and spiked with purified prothrombin to achieve prothrombin levels more than 100% of normal. Clotting was initiated by recalcifying the plasma and exposing the samples to tissue factor–bearing monocytes. Mass-to-length ratios were approximated by calculating the change in absorbance during fibrin clot formation and then normalized, such that 100% of plasma levels of prothrombin were set equal to 1. Note that the y-axis does not begin at 0. Data shown are representative of measurements on 5 separate donors. Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology

Fibrin fibers in clots formed in the presence of elevated prothrombin levels are thinner and more densely packed than fibers from normal prothrombin levels.Transmission electron micrograph of fibrin gel network from clots formed in the presence of 100% (A) ... Fibrin fibers in clots formed in the presence of elevated prothrombin levels are thinner and more densely packed than fibers from normal prothrombin levels.Transmission electron micrograph of fibrin gel network from clots formed in the presence of 100% (A) and 300% (B) plasma prothrombin levels. Fibrin fibers were thicker and less dense in the presence of 100% prothrombin (A) and thinner and more densely packed in the presence of 300% prothrombin (B). Clots were formed in microtiter wells and fixed as described in “Materials and methods.” The fibrinogen concentration was 2 mg/mL. Original magnification × 10 000; bar 0.5 μm. Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology

Fibers in fibrin clots formed in the presence of elevated prothrombin are thinner than fibers formed in the presence of normal prothrombin levels.Fibrin fibers in transmission electron micrographs of fibrin gel networks from clots formed in the presence of ... Fibers in fibrin clots formed in the presence of elevated prothrombin are thinner than fibers formed in the presence of normal prothrombin levels.Fibrin fibers in transmission electron micrographs of fibrin gel networks from clots formed in the presence of 100% and 300% plasma prothrombin levels were measured as described in “Materials and methods.” Three separate donors are depicted (1, 2, and 3). Differences in the mean thickness of fibrin fibers (horizontal lines for each data set) formed in the presence of 100% prothrombin illustrate the platelet donor-dependent differences observed in the assays.32 33 However, clots formed in the presence of 300% prothrombin were consistently composed of thinner fibers than clots formed in the presence of normal prothrombin levels (P < .0215). Alisa S. Wolberg et al. Blood 2003;101:3008-3013 ©2003 by American Society of Hematology